West Pharmaceutical Services, Inc. (NYSE:WST) Stock Position Lifted by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company grew its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 8.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,046 shares of the medical instruments supplier’s stock after acquiring an additional 5,465 shares during the quarter. The Manufacturers Life Insurance Company owned approximately 0.09% of West Pharmaceutical Services worth $22,743,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Steward Partners Investment Advisory LLC raised its holdings in shares of West Pharmaceutical Services by 108.5% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 738 shares of the medical instruments supplier’s stock worth $260,000 after purchasing an additional 384 shares during the period. CWA Asset Management Group LLC acquired a new stake in West Pharmaceutical Services during the fourth quarter worth about $250,000. NEOS Investment Management LLC lifted its holdings in West Pharmaceutical Services by 163.8% in the fourth quarter. NEOS Investment Management LLC now owns 1,965 shares of the medical instruments supplier’s stock worth $692,000 after acquiring an additional 1,220 shares during the last quarter. Blueshift Asset Management LLC boosted its stake in West Pharmaceutical Services by 189.7% in the fourth quarter. Blueshift Asset Management LLC now owns 1,799 shares of the medical instruments supplier’s stock valued at $633,000 after acquiring an additional 1,178 shares during the period. Finally, Copperwynd Financial LLC grew its holdings in shares of West Pharmaceutical Services by 4.0% during the fourth quarter. Copperwynd Financial LLC now owns 778 shares of the medical instruments supplier’s stock valued at $274,000 after purchasing an additional 30 shares during the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.

West Pharmaceutical Services Trading Down 0.1 %

Shares of NYSE WST opened at $299.72 on Wednesday. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70. The company has a market cap of $21.74 billion, a price-to-earnings ratio of 39.54, a price-to-earnings-growth ratio of 11.09 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The stock’s 50 day simple moving average is $301.24 and its 200 day simple moving average is $333.73.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. During the same period last year, the firm posted $2.11 EPS. The business’s revenue was down 6.9% compared to the same quarter last year. Equities research analysts expect that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current year.

Insider Buying and Selling at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.